Of note, enzymatic dysfunction such as PDI can result in pathological outcomes such as neurodegenerative disease and diabetes.44 The chemical structure-based design for semi-enzymatic agents that can replace the enzymes may thus give clues to new approaches for preventing enzyme-related pathogenic protein aggregation. Here, P4HB is linked to diabetes mellitus.